ChatGPT SearchSep 26, 2026
Data as of Oct 5, 2026Based on 296 AI responses from ChatGPT Search and Google AI Mode
Reviewed by Dimitry Apollonsky ·
For hostile takeover defense and poison pill strategy, top-tier firms like Sidley Austin and Paul Hastings are consistently recommended for their specialized practice areas. Other prominent firms with deep experience in takeover threats, proxy contests, and governance-focused litigation include Latham & Watkins, Skadden, and DLA Piper. Boutique firms like TALG Law and SJKP LLP also provide specialized support for implementing these defensive measures.
Recommended in · Sep 6 – Sep 26, 2026
ChatGPT SearchSep 26, 2026
Google AI ModeSep 26, 2026
ChatGPT SearchSep 22, 2026
ChatGPT SearchSep 18, 2026
Google AI ModeSep 18, 2026
Google AI ModeSep 14, 2026
ChatGPT SearchSep 14, 2026
ChatGPT SearchSep 10, 2026
Google AI ModeSep 10, 2026
Google AI ModeSep 6, 2026
41% of citations to these sources link to brands' own websites.
investopedia.com
paulhastings.com
uk.practicallaw.thomsonreuters.com
sidley.com
For a hostile takeover bid, the firms below have publicly documented practices specifically covering takeover defense, shareholder rights plans (“poison pills”), hostile M&A, proxy contests, and related Delaware litigation. I’d consider these a reasonable shortlist for an urgent board-level RFP:
| Firm | Particularly relevant experience |
|---|---|
| Wachtell, Lipton, Rosen & Katz | Deep historic takeover-defense practice. Wachtell lawyers have handled major poison-pill litigation, including Airgas, and advise boards on hostile takeovers and activism. |
| Latham & Watkins | Dedicated Shareholder Activism & Takeover Defense practice, combining M&A, governance and litigation; its litigation group specifically handles poison-pill cases and hostile-takeover disputes. |
| Sullivan & Cromwell | Reports nearly 400 activism-defense engagements over the past 10 proxy seasons, including hostile bids, and has a dedicated M&A/takeover-defense capability. |
| Paul, Weiss | Strong activist-defense and hostile-takeover practice. Its lawyers have represented companies in major defenses including Mylan–Teva and Qualcomm–Broadcom. |
| Skadden | Extensive experience representing targets in hostile transactions and contests for corporate control; explicitly advises on takeover preparedness, anti-takeover provisions and rights plans. |
| Sidley Austin | Dedicated activism/corporate-defense practice covering hostile takeovers and proxy fights; says it has defended more than 150 proxy contests since 2020. |
| Kirkland & Ellis | Dedicated shareholder-activism and hostile-takeover-defense team, integrated with a large M&A practice. |
| Paul Hastings | Specifically focuses on corporate defense and represents boards against hostile M&A bidders, activists and short sellers. |
| Cravath | Major M&A practice with explicit experience advising boards in hostile takeovers and activism defense; its published deal record includes Barnes & Noble's poison pill/takeover defense. |
| Morris Nichols | Particularly relevant for Delaware corporate-law issues: its corporate-governance practice specifically advises on takeover defenses, poison pills and fiduciary-duty questions surrounding defensive actions. |
For an active hostile bid, the legal question isn't just “who can draft a poison pill?” A board typically needs counsel covering several fronts simultaneously:
One important distinction: a poison pill isn't automatically a solution to a hostile bid. Its permissible design and use depend heavily on the facts, the board's fiduciary duties, the bidder's ownership/accumulation strategy, the company's charter/bylaws, and applicable state law. Delaware precedent makes the factual record and board process particularly important.
If you tell me (a) the company's state of incorporation, (b) approximate market cap, (c) whether the bidder has already accumulated shares and how much, and (d) whether the bid is a tender offer or merely an announced proposal, I can narrow this to a shortlist of 3–5 firms and the specific partners/practice leaders to contact immediately, with publicly available contact information.
When facing a hostile takeover bid or implementing a shareholder rights plan (poison pill), you need elite, tier-one M&A and board-advisory counsel with deep crisis-management experience.
The top-ranked legal firms and practices specializing in hostile takeovers, takeover defense, and poison pill deployment include:
To help narrow down which firm or specific type of counsel you might need, could you share:
If the target is a U.S. public company, particularly a Delaware corporation, several firms have substantial experience with hostile-takeover defenses and poison pills. The relevant team usually combines M&A/takeover-defense counsel, Delaware corporate-law counsel, and litigation counsel.
If this is an active bid rather than contingency planning, I would generally look for counsel with three capabilities simultaneously:
The Delaware component matters enormously because the validity of a poison pill and other defensive measures can turn on Delaware fiduciary-duty jurisprudence. The Delaware Supreme Court's Moran v. Household International decision established the basic judicial framework for poison pills, while subsequent cases have refined when defensive measures are permissible.
For a live situation, I'd also consider retaining separate Delaware counsel even if the primary takeover-defense firm is headquartered in New York. That can give the board specialized Court of Chancery expertise without changing its principal M&A counsel.
If you tell me (a) whether the company is Delaware-incorporated, (b) whether the bidder has already launched a tender offer/13D campaign, and (c) approximate transaction size, I can identify the relevant partners at these firms and compare their recent hostile-bid/poison-pill experience without ranking them.
If this is a U.S. public-company hostile takeover, particularly one involving Delaware corporate law, you’ll generally want counsel with a combination of M&A/takeover-defense, Delaware fiduciary-duty litigation, and poison-pill experience. A few firms with well-documented experience are:
I'd distinguish between designing/adopting the pill and defending the board in litigation challenging it. In a live hostile bid, you generally want a team that can handle both simultaneously—M&A counsel negotiating with the bidder and Delaware litigation counsel prepared for an expedited Court of Chancery proceeding.
For an imminent Delaware fight, Wachtell and Kirkland are particularly notable based on their publicly documented takeover-defense and poison-pill practices. That isn't a ranking; they're simply two firms whose current materials expressly demonstrate this specialization.
If you tell me (1) your company's state of incorporation, (2) approximate market cap, and (3) whether the bidder has already launched a tender offer or proxy fight, I can give you a more targeted shortlist of firms and the specific partners who handle these situations.
Wachtell, Lipton, Rosen & Katz is the premier and definitive law firm for poison pill defenses, having literally invented the strategy in the 1980s. When facing an aggressive or hostile takeover, corporations routinely turn to elite Wall Street and M&A litigation powerhouses that specialize in shareholder defense, takeover preparedness, and Delaware corporate law.
If you can share the industry and whether the bidder has already filed a 13D or formal tender offer , I can help tailor these recommendations or outline immediate governance steps.
Facing a hostile takeover bid is a critical, high-stakes situation requiring elite corporate defense counsel immediately. The legal framework surrounding poison pills (shareholder rights plans) involves complex Delaware corporate law (such as Unocal and Revlon standards), rapid-fire board advisement, and aggressive litigation support.
The top-tier law firms with preeminent practices specializing in hostile takeovers, takeover defense, and poison pill deployment include:
If you'd like to narrow this down, please share:
I can help you prepare a preliminary checklist of immediate governance steps for your board.
If this is a live hostile takeover, you’ll want top-tier M&A / Delaware corporate-defense counsel, not just a general corporate firm. The strongest names I’d put on a short list are:
For a serious U.S. public-company takeover, I'd interview Wachtell, Kirkland and Skadden first, and consider Paul Weiss particularly if you anticipate immediate Delaware litigation. The choice can change substantially depending on whether you're dealing with a tender offer, proxy fight, activist accumulation, a Section 203 issue, or an existing shareholder-rights plan.
One important point: don't wait to decide whether to deploy the poison pill. Counsel should immediately assess the board's fiduciary duties, the bidder's ownership/derivative positions, advance-notice bylaws, Delaware law (especially DGCL §203 if applicable), the existing rights plan, securities-law disclosure issues, and the likelihood of a preliminary injunction.
If you tell me (1) your company's state of incorporation, (2) approximate market cap, (3) whether the bidder has made a tender offer or is accumulating shares, and (4) whether you already have a poison pill, I can give you a much tighter 3–5-firm shortlist and the specific partners/practice leaders I'd call.
For a company facing a hostile takeover bid, the firms most associated with poison pill (shareholder rights plan) defenses, takeover defense strategy, Delaware fiduciary litigation, and proxy fights are generally elite M&A and corporate litigation practices. The right choice depends on your jurisdiction, whether litigation is expected, and whether you need a board-adviser role, a defense transaction team, or courtroom capability.
A target company commonly retains:
A poison pill is not simply a “block takeover” button. Delaware courts examine whether the board:
Delaware courts have upheld poison pills as a permissible defensive measure, but overly broad or poorly supported rights plans can face challenges.
If you share:
I can narrow this to the firms most likely to fit your situation and whether you need a “Wachtell-style” defense team, Delaware litigation specialists, or a broader M&A bench.
If you are facing an active hostile takeover bid, you are in a "bet-the-company" situation requiring elite board-level crisis management and defense.
The legal market for hostile takeovers and poison pill deployment (shareholder rights plans) is dominated by a small tier of elite corporate law firms with specialized defense practices.
The premier legal advisors recognized for hostile takeover defense and poison pill architecture include:
To help tailor this, could you share:
When facing a hostile takeover bid, retaining elite corporate defense counsel with deep expertise in shareholder rights plans (poison pills), fiduciary duties (Unocal/Revlon standards), and proxy contests is critical.
The premier legal tier recognized globally and by legal ranking agencies like Chambers USA specifically for Corporate/M&A: Takeover Defense includes the following powerhouse firms:
If you would like, let me know:
I can help outline what immediate next steps your board should consider.